Literature DB >> 21523697

Impact of endoscopic assessment and treatment on operative and non-operative management of acute oesophageal perforation.

M K Kuppusamy1, C Felisky, R A Kozarek, D Schembre, A Ross, I Gan, S Irani, D E Low.   

Abstract

BACKGROUND: Surgeons have not typically utilized an endoscopic approach for diagnosis and management of acute oesophageal perforation, mainly due to fears of increased mediastinal contamination. This study assessed the evolution of endoscopic approaches and their effect on outcomes over time in acute oesophageal perforation.
METHODS: All patients with documented acute oesophageal perforation between 1990 and 2009 were enrolled prospectively in an Institutional Review Board-approved database.
RESULTS: Of 81 patients who presented during the study period, 52 had upper gastrointestinal endoscopy for diagnosis alone (12 patients; 23 per cent) or as a component of acute management (40 patients; 77 per cent). Use of endoscopy increased from four of 13 patients in the first 5 years of the study to 20 of 24 patients in the final 5 years. Endoscopy was used in conjunction with surgery in 28 patients, of whom 21 underwent primary repair, three had resection, and one a diversion; 12 patients in this group had hybrid operations (combination of surgical and endoscopic management). Primary endoscopic treatment was used in 15 patients (29 per cent), most commonly involving stent placement (7). Of those having endoscopy, complication rates improved (from 3 of 4 to 8 of 20 patients), as did mean length of stay (from 21·8 to 13·4 days) between the initial and final 5 years of the study. There were two deaths (4 per cent). Of 21 patients who had both endoscopic assessment and management in the operating room, endoscopy identified additional pathology in ten, leading to a change in management plan in five patients.
CONCLUSION: Endoscopy is a safe and important component of the management of acute oesophageal perforation. It provides additional information that modifies treatment, and its wider use should result in improved outcomes.
Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21523697     DOI: 10.1002/bjs.7437

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  6 in total

Review 1.  Role of endoscopic clipping in the treatment of oesophageal perforations.

Authors:  György Lázár; Attila Paszt; Eszter Mán
Journal:  World J Gastrointest Endosc       Date:  2016-01-10

Review 2.  [Surgical treatment of acute mediastinitis].

Authors:  M Krüger; S Decker; J P Schneider; A Haverich; O Schega
Journal:  Chirurg       Date:  2016-06       Impact factor: 0.955

3.  Surgical endoscopic vacuum therapy for anastomotic leakage and perforation of the upper gastrointestinal tract.

Authors:  F Kuehn; L Schiffmann; B M Rau; E Klar
Journal:  J Gastrointest Surg       Date:  2012-09-05       Impact factor: 3.452

Review 4.  Endoscopic vacuum therapy for various defects of the upper gastrointestinal tract.

Authors:  Florian Kuehn; Gunnar Loske; Leif Schiffmann; Michael Gock; Ernst Klar
Journal:  Surg Endosc       Date:  2017-01-11       Impact factor: 4.584

5.  British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults.

Authors:  Anjan Dhar; Hasan N Haboubi; Stephen E Attwood; Marcus K H Auth; Jason M Dunn; Rami Sweis; Danielle Morris; Jenny Epstein; Marco R Novelli; Hannah Hunter; Amanda Cordell; Sharon Hall; Jamal O Hayat; Kapil Kapur; Andrew Robert Moore; Carol Read; Sarmed S Sami; Paul J Turner; Nigel J Trudgill
Journal:  Gut       Date:  2022-05-23       Impact factor: 31.793

6.  Early diagnosis is associated with improved clinical outcomes in benign esophageal perforation: an individual patient data meta-analysis.

Authors:  Bram D Vermeulen; Britt van der Leeden; Jawad T Ali; Tomas Gudbjartsson; Michael Hermansson; Donald E Low; Douglas G Adler; Abraham J Botha; Xavier B D'Journo; Atila Eroglu; Lorenzo E Ferri; Christoph Gubler; Jan Willem Haveman; Lileswar Kaman; Richard A Kozarek; Simon Law; Gunnar Loske; Joerg Lindenmann; Jung-Hoon Park; J David Richardson; Paulina Salminen; Ho-Yong Song; Jon A Søreide; Manon C W Spaander; Jeffrey N Tarascio; Jon A Tsai; Tim Vanuytsel; Camiel Rosman; Peter D Siersema
Journal:  Surg Endosc       Date:  2020-07-17       Impact factor: 4.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.